Cargando…

Dissecting the Therapeutic Mechanisms of Sphingosine-1-Phosphate Receptor Agonism during Ischaemia and Reperfusion

Sphingosine 1-phosphate (S1P) and S1P receptors (S1PR) regulate many cellular processes, including lymphocyte migration and endothelial barrier function. As neutrophils are major mediators of inflammation, their transendothelial migration may be the target of therapeutic approaches to inflammatory c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilkins, Georgina C., Gilmour, Jenny, Giannoudaki, Eirini, Kirby, John A., Sheerin, Neil S., Ali, Simi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342646/ https://www.ncbi.nlm.nih.gov/pubmed/37446370 http://dx.doi.org/10.3390/ijms241311192

Ejemplares similares

Ischaemia reperfusion injury: mechanisms of progression to chronic graft dysfunction
por: Situmorang, Gerhard R., et al.
Publicado: (2018)

Alleviating early demyelination in ischaemia/reperfusion by inhibiting sphingosine‐1‐phosphate receptor 2 could protect visual function from impairment
por: Xue, Jingfei, et al.
Publicado: (2023)

Vascular biology: the role of sphingosine 1-phosphate in both the resting state and inflammation
por: Swan, David J, et al.
Publicado: (2010)

Correspondence: Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury
por: Cilibrizzi, Agostino
Publicado: (2018)

Correspondence: Reply to ‘Compound 17b and formyl peptide receptor biased agonism in relation to cardioprotective effects in ischaemia-reperfusion injury’
por: Qin, Cheng Xue, et al.
Publicado: (2018)

Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer
por: Xu, Guangmeng, et al.
Publicado: (2021)

Mitochondrial mechanisms and therapeutics in ischaemia reperfusion injury
por: Martin, Jack L., et al.
Publicado: (2018)

The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis
por: Masuda-Kuroki, Kana, et al.
Publicado: (2023)

Inhibition of Sphingosine-1-Phosphate Receptor 2 Prevents Thoracic Aortic Dissection and Rupture
por: Pan, Guangwei, et al.
Publicado: (2021)

Hyperglycemia‐Triggered Sphingosine‐1‐Phosphate and Sphingosine‐1‐Phosphate Receptor 3 Signaling Worsens Liver Ischemia/Reperfusion Injury by Regulating M1/M2 Polarization
por: Hu, Yuanchang, et al.
Publicado: (2019)

Sphingosine protects aging hearts from ischemia/reperfusion injury: Superiority to sphingosine 1-phosphate and ischemic pre- and post-conditioning
por: Vessey, Donald A, et al.
Publicado: (2009)

The dysregulation of metabolic pathways and induction of the pentose phosphate pathway in renal ischaemia–reperfusion injury
por: Scantlebery, Angelique ML, et al.
Publicado: (2021)

Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia–reperfusion injury?
por: Gavins, Felicity N.E.
Publicado: (2010)

Selective deletion of the endothelial sphingosine-1-phosphate 1 receptor exacerbates kidney ischemia-reperfusion injury
por: Ham, Ahrom, et al.
Publicado: (2013)

Characterizing Sphingosine Kinases and Sphingosine 1-Phosphate Receptors in the Mammalian Eye and Retina
por: Porter, Hunter, et al.
Publicado: (2018)

Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
por: Cannavo, Alessandro, et al.
Publicado: (2017)

Irisin Is Target of Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor-Mediated Signaling in Skeletal Muscle Cells
por: Pierucci, Federica, et al.
Publicado: (2023)

Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks
por: Blankenbach, Kira V., et al.
Publicado: (2016)

The Sphingosine 1-Phosphate Axis: an Emerging Therapeutic Opportunity for Endometriosis
por: Zhang, Fengrui, et al.
Publicado: (2023)

Sphingosine 1-Phosphate and Atherosclerosis
por: Kurano, Makoto, et al.
Publicado: (2018)

Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target
por: Ziegler, Melanie, et al.
Publicado: (2019)

Putative therapeutic impacts of cardiac CTRP9 in ischaemia/reperfusion injury
por: Sadat‐Ebrahimi, Seyyed‐Reza, et al.
Publicado: (2022)

Sphingosine‐1‐phosphate improves outcome of no‐reflow acute myocardial infarction via sphingosine‐1‐phosphate receptor 1
por: Polzin, Amin, et al.
Publicado: (2022)

Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia
por: Dobierzewska, Aneta, et al.
Publicado: (2016)

Molecular mechanism of agonism and inverse agonism in ghrelin receptor
por: Qin, Jiao, et al.
Publicado: (2022)

Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?
por: Vestri, Ambra, et al.
Publicado: (2017)

Necroptosis in Hepatosteatotic Ischaemia-Reperfusion Injury
por: Baidya, Raji, et al.
Publicado: (2020)

Complement in ischaemia–reperfusion injury and transplantation
por: Howard, Mark C., et al.
Publicado: (2021)

Sphingosine 1-Phosphate in Malaria Pathogenesis and Its Implication in Therapeutic Opportunities
por: Dhangadamajhi, Gunanidhi, et al.
Publicado: (2020)

Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer
por: Bao, Yonghua, et al.
Publicado: (2017)

Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3
por: Li, Chao, et al.
Publicado: (2015)

Deficiency of sphingosine-1-phosphate receptor 3 does not affect the skeletal phenotype of mice lacking sphingosine-1-phosphate lyase
por: Heckt, Timo, et al.
Publicado: (2019)

Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer’s disease
por: Ceccom, Johnatan, et al.
Publicado: (2014)

The therapeutic potential of GLP‐1 receptor biased agonism
por: Jones, Ben
Publicado: (2021)

Regulatory role of sphingosine kinase and sphingosine-1-phosphate receptor signaling in progenitor/stem cells
por: Ng, Mei Li, et al.
Publicado: (2018)

Sphingosine 1-Phosphate Receptor Modulators and Drug Discovery
por: Park, Soo-Jin, et al.
Publicado: (2017)

Structural insights into sphingosine-1-phosphate receptor activation
por: Yu, Leiye, et al.
Publicado: (2022)

Inverse agonism and its therapeutic significance
por: Khilnani, Gurudas, et al.
Publicado: (2011)

The creatine kinase system as a therapeutic target for myocardial ischaemia–reperfusion injury
por: Cao, Fang, et al.
Publicado: (2018)

Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: Therapeutic options
por: Bencsik, Péter, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0qt6afcdd5570m7rcgbg754vr7